Close Menu

NEW YORK (360Dx) – In vitro diagnostics firm BacterioScan announced today that it has received 510(k) clearance from the US Food and Drug Administration for its 216Dx urinary tract infection detection system.

BacterioScan said it has signed a sales and distribution agreement for the system with Thermo Fisher Scientific unit Fisher Healthcare. Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.